Chandramohan Nibe has been appointed as Vice President – Corporate Quality Operations at Megafine Pharma (P) Ltd., effective August 2025. With over three decades of experience in pharmaceutical quality management, he brings a rich blend of expertise in API and formulation quality systems, global regulatory compliance, and operational leadership. In his new role, Nibe will oversee corporate quality operations across all manufacturing sites, ensuring Megafine Pharma continues to meet and exceed international quality standards. His appointment underscores the company’s commitment to strengthening its quality framework and operational excellence.
Before joining Megafine Pharma, Nibe served as General Manager – Quality Assurance and Site Head – Quality Assurance at Biocon Limited for more than three years. During his tenure, he played a crucial role in implementing robust quality management systems, conducting supplier and internal audits, and driving compliance with regulatory agencies worldwide. His leadership at Biocon was instrumental in fostering a strong culture of quality, innovation, and continuous improvement across manufacturing operations.
Prior to Biocon, Chandramohan Nibe was associated with Emcure Pharmaceuticals Limited as Director – QA/QC, where he led the Quality Assurance and Quality Control divisions. His role involved ensuring compliance with international regulatory requirements, managing plant audits, and optimizing QA processes for global markets. His forward-thinking approach and ability to streamline systems contributed significantly to operational efficiency and product reliability at Emcure.
Nibe’s longest tenure was with Cipla Limited, where he spent over 20 years in multiple leadership roles, including Site Head – Quality API, Head – Quality Assurance API, and API Production Officer. During his extensive stint at Cipla, he was instrumental in establishing strong quality frameworks and ensuring GMP compliance across API facilities. His deep understanding of supplier audits, regulatory expectations, and process validation helped reinforce Cipla’s reputation for manufacturing excellence and adherence to global standards.
With an illustrious career spanning roles at Cipla, Emcure, Biocon, and now Megafine Pharma, Chandramohan Nibe stands out as a seasoned quality and compliance professional in the pharmaceutical industry. His appointment marks a significant milestone for Megafine Pharma, as the company continues to expand its global footprint with an unwavering focus on quality, compliance, and innovation under his leadership.